Investors Buy HCA Healthcare (HCA) on Weakness

Investors bought shares of HCA Healthcare Inc (NYSE:HCA) on weakness during trading on Friday. $44.64 million flowed into the stock on the tick-up and $19.57 million flowed out of the stock on the tick-down, for a money net flow of $25.07 million into the stock. Of all stocks tracked, HCA Healthcare had the 26th highest net in-flow for the day. HCA Healthcare traded down ($0.49) for the day and closed at $102.60

Several analysts have weighed in on the stock. Zacks Investment Research cut shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Tuesday, March 20th. Mizuho assumed coverage on shares of HCA Healthcare in a research note on Friday, March 23rd. They issued a “buy” rating and a $115.00 price objective for the company. Finally, ValuEngine cut shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Thursday. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and fifteen have assigned a buy rating to the stock. HCA Healthcare has an average rating of “Hold” and an average target price of $105.95.

The stock has a market capitalization of $36.01 billion, a PE ratio of 15.57, a P/E/G ratio of 1.01 and a beta of 0.51. The company has a current ratio of 1.39, a quick ratio of 1.17 and a debt-to-equity ratio of -7.13.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, May 1st. The company reported $2.33 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.07 by $0.26. The business had revenue of $11.42 billion during the quarter, compared to analysts’ expectations of $11.29 billion. HCA Healthcare had a net margin of 5.96% and a negative return on equity of 55.50%. The firm’s quarterly revenue was up 7.5% compared to the same quarter last year. During the same period in the prior year, the company earned $1.74 EPS. equities research analysts expect that HCA Healthcare Inc will post 8.83 EPS for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, June 29th. Investors of record on Friday, June 1st were given a dividend of $0.35 per share. This represents a $1.40 dividend on an annualized basis and a yield of 1.36%. The ex-dividend date was Thursday, May 31st. HCA Healthcare’s dividend payout ratio is 21.24%.

In other HCA Healthcare news, insider Jonathan B. Perlin sold 12,500 shares of the business’s stock in a transaction that occurred on Thursday, June 21st. The shares were sold at an average price of $108.00, for a total transaction of $1,350,000.00. Following the sale, the insider now directly owns 107,894 shares of the company’s stock, valued at approximately $11,652,552. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Deborah M. Reiner sold 1,204 shares of the business’s stock in a transaction that occurred on Tuesday, June 5th. The stock was sold at an average price of $105.00, for a total transaction of $126,420.00. Following the sale, the senior vice president now directly owns 3,432 shares in the company, valued at $360,360. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 51,974 shares of company stock valued at $5,511,523. 2.80% of the stock is owned by corporate insiders.

A number of institutional investors and hedge funds have recently bought and sold shares of HCA. Baird Financial Group Inc. bought a new stake in HCA Healthcare during the 4th quarter worth approximately $907,000. Brown Advisory Inc. bought a new stake in HCA Healthcare during the 4th quarter worth approximately $311,000. Amalgamated Bank grew its holdings in HCA Healthcare by 6.1% during the 4th quarter. Amalgamated Bank now owns 36,067 shares of the company’s stock worth $3,168,000 after acquiring an additional 2,084 shares during the last quarter. Lazard Asset Management LLC grew its holdings in HCA Healthcare by 27.7% during the 4th quarter. Lazard Asset Management LLC now owns 410,043 shares of the company’s stock worth $36,017,000 after acquiring an additional 88,841 shares during the last quarter. Finally, Geode Capital Management LLC grew its holdings in HCA Healthcare by 1.1% during the 4th quarter. Geode Capital Management LLC now owns 2,778,426 shares of the company’s stock worth $243,496,000 after acquiring an additional 29,339 shares during the last quarter. 70.33% of the stock is currently owned by hedge funds and other institutional investors.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply